BriaCell Therapeutics - Warrants (24/02/2025) Current Assets

The latest current assets for BCTXW is $25M as of April 2026. That compares with $15M in the prior-year period — up 71.7% year over year. Investors often review this figure alongside BriaCell Therapeutics - Warrants (24/02/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, BCTXW's current assets moved from $15M to $25M — a 71.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BriaCell Therapeutics - Warrants (24/02/2025)'s operating scale or balance-sheet position.

A current assets figure of $25M for BCTXW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BCTXW's current assets ($25M), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack BriaCell Therapeutics - Warrants (24/02/2025)'s current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.